Nephrocare Health Services Ltd

Nephrocare Health Services Ltd IPO

Nephrocare Health Services Ltd IPO Price Range is ₹438 - ₹460, with a minimum investment of ₹14,720 for 32 shares per lot.

Minimum Investment

₹14,720

/ 32 shares

IPO Status

Pre-application open

Price Band

₹438 - ₹460

Bidding Dates

Dec 10, 2025 - Dec 12, 2025

Issue Size

₹871.05 Cr

Lot Size

32 shares

Min Investment

₹14,720

Listing Exchange

NSE

Nephrocare Health Services Ltd IPO Application Timeline

upcoming
Open Date10 Dec 2025
Close Date12 Dec 2025
Allotment Date15 Dec 2025
Listing Date17 Dec 2025

Strengths and Risks

Strengths

Strengths

  • Indias and Asias largest dialysis chain with leadership across our markets.

  • Scale coupled with asset-light model driving cost efficiencies and operational excellence.

  • Driving clinical excellence and quality through protocols and advanced technology.

  • Organic growth augmented by proven track record of acquisitions and integration in India and internationally.

  • Patient-centric leadership and seasoned management team backed by marquee investors.

  • Driving sustainable dialysis leadership with environmental, social and governance measures.

  • Track record of sustainable growth, profitability and return.


Risks

Risks

  • Our Company and Subsidiaries are involved in certain legal and regulatory proceedings. Any adversedecision in such proceedings may have an adverse effect on our business, financial condition, cash flowsand results of operations.

  • Our business depends on the strength of our brand and reputation. Failure to maintain and enhance ourbrand and reputation, and any negative publicity and allegations in the media against us, even if untrue,may adversely affect the brand, reputation and trust in, our services, which could result in a materialadverse impact on our business, financial condition, results of operations and prospects.

  • We rely on our in-house and third-party information technology systems in providing our services andmanaging our operations, and any disruption to such systems or networks could adversely affect ourbusiness operations, reputation and financial performance.

  • We derive a substantial portion of our revenues from clinics located in southern region of India, and anyloss of business in such regions could have an adverse effect on our business, results of operations andfinancial condition.

  • We face competition from hospitals and other dialysis service providers. Any adverse effects on ourcompetitive position could result in a decline in our business, revenues, profitability and market share.

  • The dialysis services market is subject to certain threats and challenges, which if materialize, mayadversely affect our business, results of operations, financial condition and cash flows.

  • Our business depends on the demand for dialysis services, which is affected by patient preferences,economic condition, social factors, disposable income and increasing general health awareness of Indiasgeneral population, which could decline due to a variety of factors.

  • The healthcare reimbursement framework in the Philippines is subject to periodic revisions, which mayadversely affect our business, results of operations, financial condition and cash flows.

  • Annual indexation under our PPP dialysis contract in Uzbekistan may not fully mitigate inflationary andcost escalation risks, thereby adversely affecting our business, results of operations, financial conditionand cash flows.

  • We are required to furnish bank guarantees and letters of credit as part of our business operations. Ourinability to arrange such guarantees or the invocation of such guarantees may adversely affect our cashflows and financial condition.

How to Apply for Nephrocare Health Services Ltd IPO on INDmoney

  1. Download the INDmoney app and complete your KYC.
  2. Go to INDstocks → IPO, or just search “IPO”.
  3. Tap on Nephrocare Health Services Ltd IPO from the list of live IPOs.
  4. View key details like price band, lot size, and dates.
  5. Tap Apply Now and choose your number of lots.
  6. Use INDpay UPI for instant mandate tracking.
  7. Your funds will be blocked until the share allotment is finalized.

About Nephrocare Health Services Ltd

We offer comprehensive dialysis care through our network of clinics from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. We are Indias largest dialysis service provider in terms of number of patients served, clinics, cities covered, treatments performed, revenue, and EBITDA (excluding other income) in Fiscal 2025. (Source: F&S Report) In Fiscal 2025, we served 29,281 patients and completed 2,885,450 treatments in India which represented approximately 10% of the total dialysis patients in India. We have a global network of 519 clinics and are the most widely distributed dialysis network in India with an extensive pan-India network of clinics across 288 cities, as of September 30, 2025 (Source: F&S Report) and 21 States and four Union Territories. In the six months period ended September 30, 2025 and Fiscal 2025, 2024, and 2023, our revenue from operations was Rs. 4,735.01 million, Rs. 7,558.12 million, Rs. 5,661.55 million and Rs. 4,372.95 million, respectively, highest amongst major organized dialysis service chains in India (Source: F&S Report). Our Profit / (loss) for the period / year was Rs. 142.28 million, Rs. 670.96 million, Rs. 351.33 million and Rs. (117.89) million in the six months period ended September 30, 2025, Fiscals 2025, 2024and 2023, respectively. Our EBITDA (excluding other income) has consistently increased and was Rs. 1,103.10 million, Rs. 1,666.37 million, Rs. 996.58 million and Rs. 485.95 million in the six months period ended September 30, 2025, Fiscals 2025, 2024 and 2023, respectively.

Frequently Asked Questions of Nephrocare Health Services Ltd IPO

What is the size of the Nephrocare Health Services Ltd IPO?

The size of the Nephrocare Health Services Ltd IPO is ₹871.05 Cr.

What is the allotment date of the Nephrocare Health Services Ltd IPO?

Nephrocare Health Services Ltd IPO allotment date is Dec 15, 2025 (tentative).

What are the open and close dates of the Nephrocare Health Services Ltd IPO?

The Nephrocare Health Services Ltd IPO will open on Dec 10, 2025 and close on Dec 12, 2025

What is the lot size of Nephrocare Health Services Ltd IPO?

The lot size for the Nephrocare Health Services Ltd IPO is 32.

When will my Nephrocare Health Services Ltd IPO order be placed?

Your Nephrocare Health Services Ltd IPO order will be placed on Dec 10, 2025

Can we invest in Nephrocare Health Services Ltd IPO?

Yes, once Nephrocare Health Services Ltd IPO opens, you can invest in the shares of the company.

What would be the listing gains on the Nephrocare Health Services Ltd IPO?

The potential listing gains on the Nephrocare Health Services Ltd IPO will depend on various market factors and cannot be predicted with certainty.

What is 'pre-apply' for Nephrocare Health Services Ltd IPO?

'Pre-apply' for Nephrocare Health Services Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.